EVEREST MED (01952) Directors and Major Shareholders Acquire Shares Worth Over HK$38 Million

Stock News12-15

EVEREST MED (01952) announced that on December 12, 2025, Mr. Fu Wei (Non-Executive Director, Honorary Chairman of the Board, and major shareholder), Mr. Wu Yifang (Executive Director and Chairman of the Board), Mr. Luo Yongqing (Executive Director and CEO), and Mr. He Ying (Executive Director, President, and CFO) purchased 339,000, 277,000, 132,500, and 98,200 ordinary shares of the company in the open market, respectively. The total consideration exceeded HK$38 million, with an average price of approximately HK$45.01 per share.

The company was informed that, subject to market conditions and applicable laws and regulations, CBC Group (a major shareholder) has further committed to increasing its shareholding by up to 1% cumulatively within the next three to six months. The Board believes that the voluntary share purchases by directors and CBC Group’s commitment demonstrate strong confidence in the company’s future prospects and long-term development.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment